William Guyer to join Corcept as Chief Development Officer

NEXT STORY
MediciNova Reports Second Quarter 2021 Financial Results and Business Update
PREV STORY
Eldorado Gold Announces Pricing of US$500 Million Senior Notes Offering
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

iTeos Therapeutics Announces New Preliminary Data Indicating Clinical Activity with its Anti-TIGIT Antibody, EOS-448, at the AACR Annual Meeting 2021

author_avatar
NASDAQ Market News

Novartis au 2e trimestre: fortes ventes, croissance à deux chiffres du résultat opérationnel core et lancements de Zolgensma et de Piqray; prévision des ventes et du résultat revue à la hausse

author_avatar
NASDAQ Market News

Blinded Independent Validation Study of Tissue Systems Pathology Test in Determining Risk of Progression to Esophageal Cancer in Patients with Barrett’s Esophagus to be Presented at DDW 2019

author_avatar
NASDAQ Market News